US FDA approves Korean EPO drug

Published: 2009-09-24 06:57:00
Updated: 2009-09-24 06:57:00
Hanmi Pharm said on September 17 it has received approval from the U.S. Food and Drug Administration to conduct Phase I clinical trial of a new erythropoietin (EPO) for the treatment of anemia.

The company said the approval comes after successful completion of preclinical studies on LAPS-EPO (...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.